Myopia and Presbyopia Treatment Market Outlook:
Myopia And Presbyopia Treatment Market size was valued at USD 27.7 billion in 2025 and is projected to reach USD 46.8 billion by the end of 2035, rising at a CAGR of 5.4% during the forecast period, i.e., 2026-2035. In 2026, the industry size of myopia and presbyopia treatment is evaluated at USD 29.2 billion.
The patient pool of the market continues to expand due to lifestyle-related risk and demographic aging factors. As per the National Eye Institute data released in December 2024, over 150.7 million U.S. citizens are affected by refractive errors such as presbyopia and myopia. Further, the data also shows that presbyopia among adults and children is rising in East Asia. The surge in patient volume is increasing the pressure on the supply chain for both surgical and pharmacological treatments. The U.S., Switzerland, China, Germany, and India are home to most manufacturing and processing centers.
Investment in research, development, and deployment is high, with a major focus on future-oriented technologies. Trade in this industry is marked by the export of finished high-value medical devices from developed countries and the import of parts and generic APIs. For example, according to the OEC report in 2023, the U.S. exports the largest amount of ophthalmic instruments and appliances for a value of USD 1.48 billion. Producer prices of ophthalmic products have experienced inflationary pressures due to the higher R&D expenses and complexities in the supply chain, which are then transmitted along the value chain and have an effect on the consumer price index for products and treatments for vision care.
